Natera, Inc. (NTRA)
- Sector
- Biotechnology
- Last price
- $395.65
- As of
Kresmion compiles this page from NTRA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Natera, Inc. (NTRA): 8 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
See the full NTRA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NTRA on one page. Preview it with sample data, then open it live with a free account.
Preview the NTRA dossierActive signals for NTRA
- highCONSENSUS_BUY
9 tracked funds increased NTRA this 2026Q2, institutional consensus
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 6.7%, EPS $-0.47 vs $-0.5036 estimate
- highCONSENSUS_BUY
4 tracked funds increased NTRA this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +336% to NTRA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +147% to NTRA (2026Q2)
FREE, NO ACCOUNT
Every signal on NTRA, as it fires
You are seeing 5 of 26 signals recorded on NTRA since 2026-06-02.
The five above landed across 3 days. The other 21 were recorded on 2 other days. 16 of the 26 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NTRA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| COATUE MANAGEMENT LLCCUSIP 632307104 · 2026Q2 | $680M | 1.40% | , |
| D. E. Shaw & Co., Inc.CUSIP 632307104 · 2026Q2 | $347.3M | 0.17% | , |
| VIKING GLOBAL INVESTORS LPCUSIP 632307104 · 2026Q2 | $106.1M | 0.30% | , |
| CITADEL ADVISORS LLCCUSIP 632307104 · 2026Q2 | $72.1M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 632307104 · 2026Q2 | $68.7M | 0.08% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 632307104 · 2026Q2 | $39.1M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 632307104 · 2026Q2 | $8.8M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 632307104 · 2026Q2 | $1.7M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NTRA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
NTRA against its peers
NTRA's operating margin of -13.4% ranks in the 31st percentile of 20 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | NTRA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.3B USD | 3.0B USD | 36 | 20 |
| Operating margin | -13.4% | 24.8% | 31 | 20 |
| Net margin | -9.0% | 21.0% | 30 | 21 |
| Return on equity | -12.2% | 14.7% | 20 | 21 |
| P / E | n/a | 27.8x | n/a | 12 |
| 1 year | 127.2% | 29.8% | 88 | 19 |
Peers (23): ARGX, REGN, RVMD, ONC, MRNA, BIIB, ALNY, VRTX, ROIV, RPRX, BNTX, UTHR, INCY, GMAB, INSM, GILD, ASND, EXEL, AMGN, NBIX, SMMT, BBIO, HALO. Left out: CSLLY (no annual filing), IVBXF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (NTRA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow NTRA on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NTRA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.